Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +49.56%
#3 DOVU DOVU +49.39%
#4 Velvet Velvet +44.04%
#5 Black Phoenix Black Phoenix +34.54%
#6 τemplar τemplar +23.14%
#7 Cross Cross +18.32%
#8 Ribbita by Virtuals Ribbita by Virtuals +17.09%
#9 Cap Cap +16.96%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.04%
Coin of the day
Glidr Glidr
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Rang in aandelen #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Aandeelprijs
$0.08765138
Laatst gesynchroniseerd: 2025-12-23
Marktkapitalisatie
$1.11M
Verandering (1 dag)
0.45%
Verandering (1 jaar)
-28.78%
Land
CA
Handel Psyence Group Inc. (PSYG)

Categorie

Healthcare
Koersgeschiedenis voor Psyence Group Inc. (PSYG)
Hoogste slotkoers: $0.09 op 2025-12-01

Laagste slotkoers: $0.17 op 2021-01-01
Koersgeschiedenis van Psyence Group Inc. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 10.84%
2025 -20.78%
2024 -39.49%
2023 111.53%
2022 -39.61%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.18K 72.71%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $260.38 49.03%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $249.16 21.73%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $470.54 44.82%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $135.64 63.90%
US